In January, the U.S. Food and Drug Administration accepted Arrowhead Pharmaceuticals ... upfront payment and $325 million through Sarepta stock. Price Action: ARWR stock is down 8.72% at ...

We can see that Arrowhead Pharmaceuticals does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have ...